reyaz ur rasool
University of Pennsylvania
Philadelphia, United States
Review Editor
Cancer Molecular Targets and Therapeutics
University of Pennsylvania
Philadelphia, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey
New Brunswick, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Brown University
Providence, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Karolinska Institutet (KI)
Solna, Sweden
Review Editor
Cancer Molecular Targets and Therapeutics
Moffitt Cancer Center
Tampa, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Review Editor
Cancer Molecular Targets and Therapeutics
School of Public Health, Nantong University
Nantong, China
Review Editor
Cancer Molecular Targets and Therapeutics
Weill Cornell Medical Center, NewYork-Presbyterian
New York City, United States
Review Editor
Cancer Molecular Targets and Therapeutics
National Research Council Canada (NRC)
Ottawa, Canada
Review Editor
Cancer Molecular Targets and Therapeutics
Massachusetts Institute of Technology
Cambridge, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Austral University
Buenos Aires, Argentina
Review Editor
Cancer Molecular Targets and Therapeutics
CHIC Compiégne-Noyon
Compiègne, France
Review Editor
Cancer Molecular Targets and Therapeutics
Department of Oncology, Haukeland University Hospital
Bergen, Norway
Review Editor
Cancer Molecular Targets and Therapeutics
ONK THERAPEUTICS INC
San Diego, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Sylvester Comprehensive Cancer Center, University of Miami Health System
Miami, United States
Review Editor
Cancer Molecular Targets and Therapeutics
Harvard Medical School
Boston, United States
Review Editor
Cancer Molecular Targets and Therapeutics